Cargando…

Distributed Drug Discovery, Part 1: Linking Academia and Combinatorial Chemistry to Find Drug Leads for Developing World Diseases

Detalles Bibliográficos
Autores principales:	Scott, William L., O’Donnell, Martin J.
Formato:	Texto
Lenguaje:	English
Publicado:	American Chemical Society 2008
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2651689/ https://www.ncbi.nlm.nih.gov/pubmed/19105724 http://dx.doi.org/10.1021/cc800183m

Ejemplares similares

Is combinatorial chemistry on the right track for drug discovery?
por: Wildonger, Richard A., et al.
Publicado: (2003)

HTS and hit finding in academia – from chemical genomics to drug discovery
por: Frearson, Julie A., et al.
Publicado: (2009)

Early Probe and Drug Discovery in Academia: A Minireview
por: Roy, Anuradha
Publicado: (2018)

The integration of functional genomics, combinatorial chemistry and nanotechnology into a miniaturized drug discovery process
por: Auer, M
Publicado: (2001)

Natural products and drug discovery: a survey of stakeholders in industry and academia
por: Amirkia, Vafa, et al.
Publicado: (2015)

Distributed Drug Discovery, Part 3: Using D(3) Methodology to Synthesize Analogs of an Anti-Melanoma Compound
por: Scott, William L., et al.
Publicado: (2008)

Recent advances in combinatorial biosynthesis for drug discovery
por: Sun, Huihua, et al.
Publicado: (2015)

Protein crystallography and drug discovery: recollections of knowledge exchange between academia and industry
por: Blundell, Tom L.
Publicado: (2017)

Linking academia and industry to bring drugs to the clinic: an interview with George Tidmarsh
Publicado: (2013)

The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development
por: Takebe, Tohru, et al.
Publicado: (2018)

Academia–Industry Symbiosis in Organic Chemistry
por: Michaudel, Quentin, et al.
Publicado: (2015)

Perturbational Gene-Expression Signatures for Combinatorial Drug Discovery
por: Huang, Chen-Tsung, et al.
Publicado: (2019)

TrendyGenes, a computational pipeline for the detection of literature trends in academia and drug discovery
por: Serrano Nájera, Guillermo, et al.
Publicado: (2021)

Protein-Directed Dynamic Combinatorial Chemistry: An Efficient Strategy in Drug Design
por: Canal-Martín, Andrea, et al.
Publicado: (2020)

Burger's medicinal chemistry and drug discovery
Publicado: (1996)

Frontiers in Computational Chemistry for Drug Discovery
por: Luque, F. Javier
Publicado: (2018)

CDA: Combinatorial Drug Discovery Using Transcriptional Response Modules
por: Lee, Ji-Hyun, et al.
Publicado: (2012)

Fragment Linking and Optimization of Inhibitors of the Aspartic Protease Endothiapepsin: Fragment‐Based Drug Design Facilitated by Dynamic Combinatorial Chemistry
por: Mondal, Milon, et al.
Publicado: (2016)

A Candidate for Multitopic Probes for Ligand Discovery in Dynamic Combinatorial Chemistry
por: Yoneyama, Keiko, et al.
Publicado: (2019)

Virtual Combinatorial Chemistry and Pharmacological Screening: A Short Guide to Drug Design
por: Suay-García, Beatriz, et al.
Publicado: (2022)

Encoded Library Technologies as Integrated Lead Finding Platforms for Drug Discovery
por: Ottl, Johannes, et al.
Publicado: (2019)

DrugCombDB: a comprehensive database of drug combinations toward the discovery of combinatorial therapy
por: Liu, Hui, et al.
Publicado: (2020)

Combinatorial chemistry : a practical approach /
Publicado: (2000)

Combinatorial chemistry : synthesis, analysis, screening /
Publicado: (1999)

Academia–Pharma Intersect: Providing a Broader Perspective on Drug Development Synergies between Academia and Industry
por: Chabner, Bruce A.
Publicado: (2010)

Q&A on working part-time in academia
Publicado: (2023)

Drug Repurposing for Rare Diseases: A Role for Academia
por: van den Berg, Sibren, et al.
Publicado: (2021)

Correction to ‘DrugCombDB: a comprehensive database of drug combinations toward the discovery of combinatorial therapy’
por: Liu, Hui, et al.
Publicado: (2021)

Chemistry, Pharmacology and Therapeutic Potential of Swertiamarin – A Promising Natural Lead for New Drug Discovery and Development
por: Muhamad Fadzil, Nur Sakinah, et al.
Publicado: (2021)

Facilitating Anti-Cancer Combinatorial Drug Discovery by Targeting Epistatic Disease Genes
por: Quan, Yuan, et al.
Publicado: (2018)

Distributed Drug Discovery, Part 2: Global Rehearsal of Alkylating Agents for the Synthesis of Resin-Bound Unnatural Amino Acids and Virtual D(3) Catalog Construction
por: Scott, William L., et al.
Publicado: (2008)

Coalition of Biology and Chemistry for Ameliorating Antimicrobial Drug Discovery
por: Dhakal, Dipesh, et al.
Publicado: (2017)

Strategies to Address Challenges in Neuroscience Drug Discovery and Development
por: O’Donnell, Patricio, et al.
Publicado: (2019)

Protein-Directed Dynamic Combinatorial Chemistry: A Guide to Protein Ligand and Inhibitor Discovery
por: Huang, Renjie, et al.
Publicado: (2016)

Spirotetronate Polyketides as Leads in Drug Discovery
por: Lacoske, Michelle H., et al.
Publicado: (2014)

MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery
por: Wooten, David J., et al.
Publicado: (2021)

A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2020)

Computational Approaches: Drug Discovery and Design in Medicinal Chemistry and Bioinformatics
por: Tutone, Marco, et al.
Publicado: (2021)

Recent updates in click and computational chemistry for drug discovery and development
por: Cai, Jiang Hong, et al.
Publicado: (2023)

Solid-Phase Synthesis of Arylpiperazine Derivatives and Implementation of the Distributed Drug Discovery (D3) Project in the Search for CNS Agents
por: Zajdel, Paweł, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_k6ftmhdkn6qed5o5j1o1cbp2hg